SGMO Financial Facts

Loss from operations: -7.65M
Net loss: -7.55M
See Full Income Statement

Total liabilities and stockholders' equity: 247.35M
Accumulated deficit: -324.23M
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date 5/6/15 *Est. EPS Growth Rate +53.8% *Last Qtr.
Average EPS % Beat Rate +22.8% Revenue Growth Rate +116.7% *Last Qtr.
Average % Move 1-Wk after EPS +8.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/10/15 Q414 -$0.06-$0.09 +$0.03$14.95M$14.5M = Details
10/22/14 Q314 -$0.11-$0.14 +$0.03$12.4M$8.27M = Details
7/23/14 Q214 -$0.10-$0.14 +$0.04$10.4M$7.84M = Details
5/6/14 Q114 -$0.12-$0.13 +$0.01$8.1M$6.59M = Details
2/11/14 Q413 -$0.13N/A N/A $6.9M$8.9M = Details
10/23/13 Q313 -$0.11-$0.11 $0.00$5.7M$5.52M = Details
7/24/13 Q213 -$0.10-$0.13 +$0.03$6.93M$4.77M = Details
5/8/13 Q113 -$0.13-$0.16 +$0.03$4.62M$3.79M = Details